Inhibitory effects of ONO-3708 and S-145 on shape change and aggregation of rabbit platelets induced by STA2

Acta Pharmacologica Sinica

Volumn 17, Issue 4, 1996, Pages 345-348

  Li, Bai Yan ^a   Qiao, Guo Fen ^a   Sun, Jian Ping ^a   Gao, Yun Rui ^a   Li, Wen Han ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

blood platelets; calcium; ONO 3708; platelet aggregation; platelet aggregation inhibitors; S 145; STA2; thromboxane A2

Indexed keywords

15 CYCLOPENTYL 14 OXO 13 AZA 16,17,18,19,20 PENTANORPINANE THROMBOXANE A2; 7 (3 BENZENESULFONAMIDOBICYCLO[2.2.1]HEPT 2 YL) 5 HEPTENOIC ACID; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR;

ANIMAL CELL; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; NONHUMAN; RABBIT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE SHAPE;

ANIMALS; BICYCLO COMPOUNDS; BLOOD PLATELETS; FATTY ACIDS, MONOUNSATURATED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN ANTAGONISTS; RABBITS; RECEPTORS, THROMBOXANE; THROMBOXANE A2;

EID: 0029784219     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Siess W, Boehlig B, Weber PC, Lapetina EG. Prostaglandin endoperoxide analogues stimulate phospholipase C and protein phosphorylation during platelet shape change. Blood 1985; 65: 1141-8.
2. Halushka PV, Mais DE, Mayeux PR, Morinelli TA. Thromboxane, prostaglandin and leukotrine receptor. Annu Rev Pharmacol Toxicol 1989; 29: 213-39.
3. Narumiya S, Okuma M, Ushikubi F. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species. Br J Pharmacol 1986; 88: 323-31.
4. 2 analogues in human platelets. J Biol Chem 1990; 265: 6836-44.
5. 2 receptor from human blood platelets. J Biol Chem 1989; 264: 16496-501.
6. 2+]i mobilization in rabbit platelets. Acta Pharmacol Sin 1995; 16: 108-13.
7. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
8. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
9. 2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther 1991; 258: 74-81.
10. 2 receptor. Nature 1991; 349: 617-20.